WCN26-5139 Lysophosphatidylserine modulates the IgA nephropathy phenotype in HIGA mice

Read full text Summarise with VIRAT
Authors: Makoto Kurano, Teruhiko Yoshida, Yoshifumi Morita, Zhang Na, Koichi Tsuneyama, Yutaka Yatomi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Lysophosphatidylserine (LysoPS) is a rather novel lysophospholipids mediator, which exerts several physiological properties, especially in the fields of immune response, through its three GPCRs, GPR34, P2Y10, and GPR174. In this study, we aimed to elucidate the potential roles of LysoPS in the pathogenesis of kidney diseases, using HIGA mice, a murine IgA nephropathy model.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Sphingolipid Metabolism and Signaling Systemic Lupus Erythematosus Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106020–106020
Publication date
25 March 2026
Language
EN